Related Experiment Video

Updated: Aug 11, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

CFTR and pseudomonas infections in cystic fibrosis

L E Tatterson1, J F Poschet, A Firoved

  • 1Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109-0620, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|August 7, 2001
PubMed

Insights

Pseudomonas aeruginosa infections pose a major threat, especially to cystic fibrosis (CF) patients. This review focuses on the factors that make CF patients susceptible to P. aeruginosa colonization and infection.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pseudomonas aeruginosa is a gram-negative bacterium known for its resistance to antibiotics and disinfectants.
  • It is a significant cause of hospital-acquired and community-acquired infections, particularly in vulnerable populations.
  • P. aeruginosa poses a substantial challenge in patients with burns, neutropenia, and cystic fibrosis (CF).

Purpose of the Study:

  • This review aims to discuss the current challenges associated with P. aeruginosa infections in cystic fibrosis (CF) patients.
  • It will specifically emphasize the predisposing factors that lead to P. aeruginosa colonization in CF individuals.

Main Methods:

  • This is a review article, synthesizing existing literature on P. aeruginosa infections in CF.
  • The focus is on identifying and analyzing factors contributing to bacterial colonization.

Main Results:

  • Pseudomonas aeruginosa infections are a significant concern in cystic fibrosis patients.
  • Understanding predisposing factors is crucial for managing and preventing P. aeruginosa colonization in CF.

Conclusions:

  • Pseudomonas aeruginosa remains a critical pathogen in cystic fibrosis care.
  • Further research into predisposing factors may lead to improved therapeutic strategies and patient outcomes.

More Related Videos

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...